StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by FacBineon Apr 25, 2020 12:35am

450 Views

Post# 30952604

SZLS - top most-viewed company on the healthcare Bullboards

Last week, the top six most-viewed companies on the healthcare Bullboards nearly topped the entire site, but the peak position has continued to shift. Most recently, the honour has gone to StageZero Life Sciences Ltd. (TSX:SZLS, Forum), a recurring face on the top stocks that has had a COVID-19 related resurgence. Read more at:.... https://stockhouse.com/opinion/buzz-on-the-bullboards/2020/04/09/buzz-on-bullboards-healthcare-reigns-while-mining-falls?fbclid=IwAR0Jx972_Ybl4_3fEHjSSIguxJvHgRPLq-EpCZbjChCO9usUtQFDSZAnJho

Bullboard Posts

Cameco raises uranium output as Q3 results surge